RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,480 | -15.3% | 203,222 | +1.1% | 0.00% | – |
| Q2 2023 | $259,213 | -96.5% | 200,940 | -96.5% | 0.00% | – |
| Q1 2023 | $7,487,896 | -43.9% | 5,672,648 | -36.2% | 0.00% | -100.0% |
| Q4 2022 | $13,338,011 | -27.0% | 8,892,007 | -42.6% | 0.00% | -50.0% |
| Q3 2022 | $18,274,000 | -33.0% | 15,486,587 | -35.8% | 0.00% | -33.3% |
| Q2 2022 | $27,263,000 | -62.3% | 24,127,070 | -0.2% | 0.00% | -50.0% |
| Q1 2022 | $72,303,000 | +11.0% | 24,181,804 | -1.6% | 0.01% | +20.0% |
| Q4 2021 | $65,114,000 | -29.8% | 24,571,593 | -3.8% | 0.01% | -28.6% |
| Q3 2021 | $92,721,000 | -16.3% | 25,543,093 | +0.1% | 0.01% | -22.2% |
| Q2 2021 | $110,777,000 | +27.0% | 25,524,603 | +0.1% | 0.01% | +28.6% |
| Q1 2021 | $87,231,000 | +19.2% | 25,506,203 | +22.0% | 0.01% | 0.0% |
| Q4 2020 | $73,196,000 | +43.8% | 20,913,103 | -1.4% | 0.01% | +40.0% |
| Q3 2020 | $50,898,000 | +29.6% | 21,207,403 | -1.2% | 0.01% | +25.0% |
| Q2 2020 | $39,277,000 | +14.2% | 21,462,703 | -2.7% | 0.00% | -20.0% |
| Q1 2020 | $34,394,000 | -29.6% | 22,047,157 | -3.5% | 0.01% | 0.0% |
| Q4 2019 | $48,880,000 | +12.0% | 22,841,064 | -2.1% | 0.01% | 0.0% |
| Q3 2019 | $43,627,000 | -33.3% | 23,329,857 | -7.0% | 0.01% | -37.5% |
| Q2 2019 | $65,456,000 | +1.6% | 25,079,011 | +0.0% | 0.01% | 0.0% |
| Q1 2019 | $64,445,000 | +12.1% | 25,075,725 | +0.3% | 0.01% | 0.0% |
| Q4 2018 | $57,491,000 | -28.3% | 24,996,008 | +0.1% | 0.01% | -11.1% |
| Q3 2018 | $80,143,000 | +15.4% | 24,966,516 | +1.8% | 0.01% | +12.5% |
| Q2 2018 | $69,440,000 | -11.2% | 24,537,044 | +11.1% | 0.01% | -11.1% |
| Q1 2018 | $78,192,000 | -8.3% | 22,088,119 | +0.5% | 0.01% | -10.0% |
| Q4 2017 | $85,258,000 | +79.9% | 21,973,663 | +17.8% | 0.01% | +66.7% |
| Q3 2017 | $47,383,000 | -5.5% | 18,654,649 | +1.6% | 0.01% | 0.0% |
| Q2 2017 | $50,117,000 | -17.4% | 18,357,857 | +0.1% | 0.01% | -25.0% |
| Q1 2017 | $60,691,000 | +71.9% | 18,335,735 | +23.6% | 0.01% | +60.0% |
| Q4 2016 | $35,303,000 | -32.2% | 14,833,279 | +4.6% | 0.01% | -28.6% |
| Q3 2016 | $52,045,000 | +68.9% | 14,181,146 | +2.6% | 0.01% | +75.0% |
| Q2 2016 | $30,822,000 | +9.1% | 13,821,657 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $28,253,000 | -29.8% | 13,583,384 | +2.3% | 0.00% | -20.0% |
| Q4 2015 | $40,235,000 | +22.7% | 13,278,884 | +0.0% | 0.01% | 0.0% |
| Q3 2015 | $32,791,000 | -22.7% | 13,275,627 | +0.4% | 0.01% | 0.0% |
| Q2 2015 | $42,441,000 | -10.0% | 13,221,574 | +0.1% | 0.01% | -16.7% |
| Q1 2015 | $47,147,000 | +57.7% | 13,206,546 | +0.3% | 0.01% | +50.0% |
| Q4 2014 | $29,893,000 | +17.0% | 13,168,911 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $25,548,000 | -46.4% | 13,168,911 | +0.3% | 0.00% | -50.0% |
| Q2 2014 | $47,661,000 | -6.4% | 13,129,697 | +0.0% | 0.01% | -14.3% |
| Q1 2014 | $50,942,000 | +100.4% | 13,129,343 | +47.2% | 0.01% | +75.0% |
| Q4 2013 | $25,421,000 | -32.8% | 8,919,545 | -15.6% | 0.00% | -33.3% |
| Q3 2013 | $37,815,000 | +7.2% | 10,562,872 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $35,280,000 | – | 10,562,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |